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Abstract 1 
Lytic polysaccharide monooxygenases (LPMOs) are copper-dependent enzymes capable of the 2 
oxidative breakdown of polysaccharides. They are of industrial interest due to their ability to 3 
enhance the enzymatic depolymerization of recalcitrant substrates by glycoside hydrolases. In this 4 
paper, twenty-four lytic polysaccharide monooxygenases (LPMOs) expressed in Trichoderma 5 
reesei were evaluated for their ability to oxidize the complex polysaccharides in soybean spent 6 
flakes, an abundant and industrially relevant substrate. TrCel61A, a soy-polysaccharide-active AA9 7 
LPMO from T. reesei, was used as a benchmark in this evaluation. In total, seven LPMOs 8 
demonstrated activity on pretreated soy spent flakes, with the products from enzymatic 9 
treatments evaluated using mass spectrometry and high performance anion exchange 10 
chromatography. The hydrolytic boosting effect of the top-performing enzymes was evaluated in 11 
combination with endoglucanase and beta-glucosidase. Two enzymes (TrCel61A and Aspte6) 12 
showed the ability to release more than 36% of the pretreated soy spent flake glucose – a greater 13 
than 75% increase over the same treatment without LPMO addition.  14 
Keywords 15 
lytic polysaccharide monooxygenase; soy spent flake; soy polysaccharides; cellulose hydrolysis; 16 
Trichoderma reesei; Chaetosartorya cremea; Aspergillus fumigatus; Aspergillus terreus; Penicillium 17 
citrinum; Malbranchea cinamomea; Myceliophthora thermophila; Talaromyces leycettanus 18 
Abbreviations 19 
LPMO, lytic polysaccharide monooxygenase; HPAEC, high performance anion exchange 20 
chromatography; PASC, phosphoric acid swollen cellulose; DP, degree of polymerization 21 
22 
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1. Introduction 23 
Soybean polysaccharides are produced in large quantities globally as an industrial by-product of 24 
soy protein, soy milk, and tofu production. When resulting from tofu or soy milk production they 25 
are generally referred to as okara, and when generated as a by-product of soy protein isolate 26 
production they are known as spent flakes1. These materials are predominantly composed of high 27 
molar mass, water-insoluble cell wall polysaccharides including type I arabinogalactan, cellulose, 28 
arabinoxylan, rhamnogalacturonan, arabinan, xyloglucan, and homogalacturonan2. Each year, 29 
approximately 3.91 x 106 tons of soybean polysaccharides are produced through Chinese, 30 
Japanese and Korean tofu production, with the vast majority of this material disposed of as waste 31 
or burned3-5. This disposal not only adds significant costs to the production process, but also raises 32 
environmental sustainability concerns. It is therefore of significant interest to develop alternate 33 
applications for improved utilization of this abundant industrial by-product. 34 
Lytic polysaccharide monooxygenases (LPMOs) are copper-dependent enzymes capable of 35 
polysaccharide depolymerization through oxidation of sugar residues6. They have been classified 36 
as auxiliary activity (AA) enzymes in the Carbohydrate-Active enZyme database (CAZy; 37 
http://www.cazy.org)7, and are currently categorized into four families: AA9 (formerly GH61), 38 
AA10 (formerly CBM33), AA11, and AA13. AA9 comprises fungal LPMOs active on lignocellulose, 39 
AA10 predominantly comprises LPMOs of bacterial and viral origin cleaving cellulose and chitin, 40 
AA11 comprises fungal LPMOs that cleave chitin, and AA13 comprises fungal LPMOs that cleave 41 
starch8. The importance of this oxidative mechanism in cellulose degradation was first suggested 42 
in 1974 by Eriksson et al.9. In 2010, Vaaje-Kolstad et al. described the oxidative mode of action of 43 
LPMOs and demonstrated their capacity to boost the enzymatic degradation of chitin10. There has 44 
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been a significant amount of research into these enzymes, with LPMO activity being demonstrated 45 
for a variety of substrates including cellulose, xylan, xyloglucan, glucomannan, lichenan, starch, β-46 
glucan, and soluble cello-oligosaccharides11-16. The precise oxidative mode of action of LPMOs is 47 
still under debate, but has been postulated to involve internal electron channels17 or, more 48 
recently, Fenton-type H2O2 chemistry
18. The majority of LPMO oxidations have been observed at 49 
the C1 or C4 positions of glucose6, 19, however oxidation at the C6 position has also been 50 
suggested20. A key feature of all structurally characterized LPMOs is the presence of a histidine 51 
brace at the active site. This site coordinates to the catalytic copper ion and consists of the 52 
imidazole and amino group of an N-terminal histidine, as well as the imidazole of an additional 53 
histidine21. LPMOs which have been expressed in fungi routinely display a characteristic Nϵ 54 
methylation of the N-terminal histidine imidazole nitrogen. While the role of this modification is 55 
still unclear and under debate, it has been proposed that the presence of an alkyl group on the 56 
imidazole side chain of the N-terminal histidine could enhance the electrostatic interaction 57 
between the enzyme and the substrate22. It has also recently been suggested that this methylation 58 
may play a role in protecting fungal LPMOs from oxidative self-destruction18.  59 
One reason for the recent interest in LPMOs is their ability to boost the activity of cellulolytic 60 
enzymes in the degradation of biomass23-25. Our previous work demonstrated the ability of the 61 
AA9 LPMO TrCel61A from Trichoderma reesei to oxidize the cellulosic polysaccharides of NaOH 62 
pretreated soybean spent flakes at both the C1 and C4 positions26. In addition, TrCel61A 63 
treatment of pretreated soybean spent flakes was shown to result in a significant increase in the 64 
glucose release observed from endoglucanase (EG) treatment of this substrate. The aim of the 65 
current study is to explore the suitability of other LPMOs to degrade this complex substrate. For 66 
this purpose, twenty-three additional fungal LPMOs from seven host organisms were expressed in 67 
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a Trichoderma reesei (Hypocrea jecorina) strain deleted for select cellulase genes and beta-68 
glucosidase27. Following expression, the N-terminal protein sequence was assessed in order to 69 
verify the N-terminal histidine and evaluate the presence of the N-terminal histidine Nϵ 70 
methylation.  The activities of each LPMO were investigated against a variety of substrates 71 
(phosphoric acid swollen cellulose (PASC), native soy spent flakes, NaOH pretreated soy spent 72 
flakes, and Avicel® PH-101 microcrystalline cellulose) and oxidation products of these treatments 73 
were analyzed with ESI mass spectrometry and high performance anion exchange 74 
chromatography (HPAEC). For the LPMOs displaying activity on soy spent flakes, the effect of 75 
LPMO addition on substrate glucose release through endoglucanase (EG) and beta-glucosidase (BG) 76 
treatment was also investigated.  77 
2. Results and Discussion 78 
2.1 Protein characterization 79 
Table 1 provides a list of the twenty-four LPMOs utilized in this study. To date, the majority of 80 
these proteins have not yet been reported to have LPMO activity, with only four of them having an 81 
exact amino acid sequence match in the National Center for Biotechnology Information (NCBI) 82 
BLAST® non-redundant protein sequence database28, 29. The closest matches for all twenty-four 83 
LPMOs from a BLAST® search are provided in Supplementary Information Section 2. Note that ten 84 
of the LPMOs showed high levels of sequence homology with proteins listed in the sequence 85 
database, giving 100% sequence coverage and matching scores of at least 99% identity, 99% 86 
positives, and 0 gaps. Table 1 also contains the results of an InterPro protein sequence domain 87 
analysis indicating whether a cellulose binding domain (CBD) is predicted based on the sequences 88 
of the LPMOs analyzed30. Supplementary Information Figure S1 shows the SDS-PAGE gels obtained 89 
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for each LPMO used in this study. The presence of band spreading and increased molecular 90 
weights over those expected from the amino acid sequence demonstrate the presence of 91 
glycosylation, a common post-translational event which occurs during protein expression in fungi31. 92 
Protease digestion in combination with MS/MS-MS analysis was used to identify the N-terminal 93 
sequences of the twenty-four expressed LPMOs. A summary of the results from this analysis are 94 
presented in Supplementary Information Section 3. All twenty-four proteins were identified to 95 
primarily have N-terminal histidine residues. Chacr2 (G), Aspfu3 (G), Aspfu5 (G), Aspte1 (G), 96 
Aspte3 (G), Aspte4 (G), Aspte5 (A), Aspte6 (A), Penci1 (G), Penci2 (G), and Mycth3 (A) showed the 97 
presence of some proteins containing one additional N-terminal amino acid, indicated in 98 
parenthesis, resulting in the lack of an N-terminal histidine. While one LPMO (Penci2) showed a 99 
significant amount of expression with the amino acid addition, the relative abundance of these 100 
observed peptides for the other LPMOs were several orders of magnitude lower than peptides 101 
containing the N-terminal histidine. It is interesting to note that the majority of these amino acid 102 
additions occur with the presence of glycine immediately preceding the N-terminal histidine. In 103 
fact, only two protein sequences featuring a glycine prior to the expected terminal histidine lacked 104 
any observed N-terminal glycine addition (Malcil1 and TrCel61A). Aspfu1 (G), Aspfu2 (G), Aspfu3 105 
(G), Aspfu4 (G), Aspfu5 (G), Aspte5 (G), Aspte6 (G), Aspte7 (Y), Aspte8 (Y), Mycth1 (Y), Mycth3 (T), 106 
and Talle1 (G) showed the presence of a one amino acid truncation, with the new N-terminal 107 
amino acid indicated in parenthesis. Significant levels of the truncated sequence were observed 108 
for Aspfu4, Aspte6, Aspte7, Aspte8, and Mycth1; however, in all cases the relative abundances of 109 
these observed peptides were significantly lower than the peptides containing the N-terminal 110 
histidine. 111 
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The presence of N-terminal histidine methylation was also evaluated due to its expected presence 112 
following expression in T. reesei23. The Nϵ methylation of the N-terminal histidine was observed 113 
for all twenty-four LPMOs in this study. It is interesting to observe that the methylation from T. 114 
reesei expression is observed even though leader peptides that are not endogenous to this 115 
organism were used. For the majority of proteins, the methylated N-terminal histidine was 116 
identified as the most prominent N-terminal fragment. Ten of the proteins (Aspte1, Aspte3, 117 
Aspte4, Penci2, Aspte7, Aspte8, Malci1, Malci2, Mycth2, and TrCel61A) were observed to have 118 
methylation present on all or the vast majority of their N-terminal histidine residues.  However, a 119 
non-methylated N-terminal histidine was identified to varying degrees in the remaining fourteen 120 
proteins (Chacr1, Chacr2, Aspfu1, Aspfu2, Aspfu3, Aspfu4, Aspfu5, Aspte2, Aspte5, Aspte6, Penci1, 121 
Mycth1, Mycth3, and Talle1). For the vast majority of these proteins, peptides corresponding to 122 
the methylated N-terminal histidine were significantly more abundant than those of its non-123 
methylated counterpart. However, five of the proteins (Chacr1, Aspfu1, Aspfu2, Aspfu4, and Talle1) 124 
showed a higher abundance of the non-methylated protein. 125 
2.2 Evaluation of LPMO Activity 126 
The twenty-four LPMOs listed in Table 1 were evaluated for their ability to oxidatively cleave the 127 
polysaccharides in four substrates: PASC, native soy spent flakes, NaOH pretreated soy spent 128 
flakes, and Avicel®. The NaOH pretreatment of soy spent flakes serves to convert the cellulose I 129 
allomorph into cellulose II, in addition to reducing the cellulose crystallinity32. As previously 130 
reported, this NaOH pretreatment results in a reduction of substrate hemicellulose and a 131 
corresponding enrichment in cellulosic polysaccharides. The molar percentages of galactose, 132 
arabinose, glucose, and xylose for the native spent flakes are 34.65%, 20.67%, 19.16%, and 8.37%, 133 
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respectively. Following NaOH pretreatment, these levels change to 15.30%, 12.56%, 51.77%, and 134 
6.08%, respectively26.  This reduction in substrate hemicellulose may also lead to the additional 135 
benefit of increased substrate accessibility during enzymatic treatment.  136 
Table 2 shows the results of this substrate screening, with the lack of activity (-) or presence and 137 
degree of activity (+, ++, or +++) indicated for each enzyme. The degree of activity was assessed 138 
using ESI-MS to determine the presence of DP 2-6 oxidized oligomers following the 24 hr enzyme 139 
treatment. For a given neutral oligomer of mass M, samples were evaluated for signals 140 
characteristic of LPMO oxidation such as a [M-2] signal indicating C4-ketone oxidation and a 141 
[M+16] signal characteristic of either C1-aldonic acid oxidation and/or C4-gemdiol oxidation. The 142 
results for this full in-depth analysis are provided in Supplementary Information Section 4, but 143 
have been condensed to a single activity level per enzyme for a given substrate in Table 2. Twenty-144 
one of the LPMOs investigated in this study demonstrated some degree of oxidative activity on 145 
PASC after 24 hrs. The lack of observed activity on PASC for Aspte1, Mycth1, and Mycth3 may 146 
indicate that the enzyme treatment conditions utilized in this study were not sufficient for these 147 
enzymes to produce enough detectable product. While all LPMO treatments presented in this 148 
study were standardized at equivalent protein levels, the relative amount of LPMO protein in each 149 
enzyme sample may have differed due to the lack of extensive purification. For this reason, it is 150 
possible that the relative levels of LPMO protein for these three enzyme treatments were too low 151 
for activity to be observed. It can be observed from Table 1 that these three LPMOs lack a 152 
predicted cellulose binding domain (CBD) at the C-terminus of the protein; however, there does 153 
not appear to be a clear correlation between the presence of a predicted CBD and activity for the 154 
LPMOs investigated in this study. It is also possible that these three proteins simply do not have 155 
LPMO activity on the substrates investigated in this study. The lack of activity cannot be directly 156 
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linked to the N-terminal characterization data presented in 2.1 and Supplementary Information 157 
Section 3, as all three enzymes displayed the required N-terminal histidine following expression.  158 
No oxidative activity was observed for any of the LPMOs on the native soy spent flakes; however, 159 
seven of the LPMOs investigated (TrCel61A, Chacr2, Aspfu1, Aspfu4, Aspfu5, Aspte6, and Talle1) 160 
did show activity on the NaOH pretreated spent flakes. This finding matches our previously 161 
reported results concerning the activity of TrCel61A on soy polysaccharides, and also indicates 162 
that the complex polysaccharides of soybean are highly resistant to oxidative degradation by 163 
LPMOs using the conditions employed in this study26. While the exact structural relationship 164 
between the cellulosic and hemicellulosic polysaccharides in soybean has not yet been fully 165 
characterized, it can be hypothesized from these findings that the hemicellulose is capable of 166 
shielding the cellulose from enzymatic attack by LPMOs.  It is interesting to note from Table 2 that 167 
all LPMOs which showed activity on the NaOH pretreated soy spent flakes also showed strong 168 
activity on PASC and some degree of activity on the crystalline cellulose in Avicel®. This 169 
commonality between Avicel® activity and NaOH pretreated soy spent flake activity suggests a 170 
degree of similarity between these two substrates, and may be an indication of remaining 171 
cellulose crystallinity in the spent flakes despite the pretreatment employed in this study. While 172 
this trend is almost universal for the LPMOs considered in this study, it was observed that Aspte2 173 
showed no detectable activity on NaOH pretreated spent flakes despite its observed activity on 174 
both PASC and Avicel®.  175 
From the seven LPMOs showing activity on the pretreated spent flakes, three were selected as the 176 
top-performing enzymes (TrCel61A, Aspte6, and Talle1) for further screening based on the 177 
abundance of oxidized products detected with ESI MS. Figure 1 shows the ESI MS-MS CID 178 
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fragmentation spectra of the sodiated and oxidized [M+16-Na]+ ion (m/z 381.10) following the 179 
LPMO treatment of PASC with these three LPMOs. The fragments have been labeled with the 180 
nomenclature of Domon and Costello33, with Figure 1D illustrating the possible fragmentation 181 
products for both the C4 oxidized gemdiol, Glc4gemGlc (blue), and the C1 oxidized aldonic acid, 182 
GlcGlc1A (red) as described by Isaksen et al.16. As was previously reported26, TrCel61A 183 
demonstrates characteristics of both C1 and C4 oxidation following treatment with PASC (Figure 184 
1A). Characteristic C4 fragmentations include the loss of two water molecules (m/z 363.09 and 185 
345.08); the presence of 0,2A2-H2O (m/z 303.07) and 
3,5A2 (m/z 275.07); the prominent Y1 peak (m/z 186 
203.05); and loss of water in the B1 fragment (m/z 183.02). Characteristic C1 fragmentations 187 
include the characteristic loss of a carboxyl group ((0),1A2; m/z 335.09) and the presence of a large 188 
Y1 fragment (m/z 219.05). While this latter signal could also correspond to the C1 fragment of C4 189 
oxidation, this fragment is expected to be in low abundance after undergoing rapid dehydration 190 
and has therefore been marked in parenthesis to indicate this effect. 191 
Comparing Figure 1A to the other LPMO treatments, we continue to observe the characteristic C4 192 
oxidation fragments; however, fragmentations characteristic of C1 oxidation ((0),1A2; Y1) are no 193 
longer present.  This is evidenced by the lack of observed signals corresponding exclusively to C1 194 
oxidation (red). In particular, the low signals observed for the (C1)/Y1 fragment (m/z 219.05) for 195 
the non-TrCel61A LPMO treatments indicate a lack of C1 oxidation. Aspte6 and Talle1 show an 196 
additional C4 oxidation fragment, 3,5X2, not observed in the TrCel61A sample; however, they also 197 
lack the C1/C4 oxidation fragment 2,4X1/
(0),2A2, which is observed in the TrCel61A sample. In order 198 
to further explore the observation that all LPMOs showing activity on NaOH pretreated spent 199 
flakes demonstrate C4 oxidation, HPAEC-PAD profiles were run to analyze the oxidation products. 200 
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Figure 2 shows the HPAEC-PAD chromatograms of the products produced by these three enzymes 201 
on NaOH pretreated soy spent flakes both with (black) and without (red) ascorbic acid as a 202 
reductant. In addition, the elution pattern of the neutral cello-oligomers from DP 2-6 is presented 203 
for reference (Figure 2D). In the presence of ascorbic acid, signals are observed in the 204 
characteristic neutral (~5-22 min), C1 oxidized (~20-30 min), C4 oxidized (~30-40 min), and C1-C4 205 
oxidized (~40-46 min) regions of this chromatogram as described by Westereng et al.34. The 206 
strongest signals are observed for TrCel61A and Aspte6, corresponding well to the strength of 207 
LPMO activity summarized in Table 2. Both of these enzymes show evidence of C1 and C4 208 
oxidation (Figure 2A and 2B), while Talle1 shows the majority of its signals in the C4 oxidation 209 
region (Figure 2C). While signals are observed in the late-eluting C1-C4 oxidized region, the 210 
presence of additional signals in this region both with and without ascorbic acid makes it difficult 211 
to unambiguously confirm the presence of these doubly oxidized products.  212 
To further investigate the observed correlation between C4 oxidation and activity on the 213 
pretreated spent flakes, additional HPAEC-PAD experiments were conducted where the soluble 214 
fractions following LPMO treatment of PASC were further treated with BG.  Due to the non-215 
reducing end activity of BG, this treatment will result in degradation of neutral and C1 oxidized 216 
soluble oligomers, but will leave the C4 oxidized compounds intact due to their modified non-217 
reducing end.  Evaluating the HPAEC-PAD chromatograms of all BG treated LPMO samples for 218 
retained signals in the C4 oxidized region (~30-40 min), we observe that seven enzymes (TrCel61A, 219 
Chacr2, Aspfu3, Aspfu4, Aspfu5, Aspte6, and Talle1) continue to show strong evidence of C4 220 
oxidation and four enzymes (Aspfu1, Aspte2, Aspte3, and Aspte4) show weak evidence of C4 221 
oxidation (results not shown). All other LPMOs show no signals in this region of the chromatogram, 222 
indicating that no C4 oxidation took place. Comparing these results to the activity data presented 223 
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in Table 2, we observe that all LPMOs demonstrating activity on the NaOH pretreated spent flakes 224 
also show confirmed C4 oxidation. In addition, the three top-performing enzymes (TrCel61A, 225 
Aspte6, and Talle1) selected above show strong C4 oxidation, confirming the MS-MS results 226 
presented in Figure 1. It is interesting to note that four LPMOs (Aspfu3, Aspte2, Aspte3, and 227 
Aspte4) showed evidence of C4 oxidation, but no activity on the pretreated spent flakes. Lastly, it 228 
should be noted that all oxidation effects described above were absent in control samples treated 229 
with each LPMO in the absence of ascorbic acid (results not shown).  230 
2.3 Hydrolytic boosting effect between LPMO, endoglucanase, and beta-glucosidase on soy spent 231 
flakes 232 
In our previous work, we demonstrated the hydrolytic boosting capability of TrCel61A when dosed 233 
in combination with EG for the enzymatic degradation of NaOH pretreated spent flakes26. In order 234 
to further explore this effect, the top-performing LP Os described in Section 2.2 were evaluated 235 
for their hydrolytic boosting ability. Figure 3 shows the HPAEC measured glucose release from 236 
NaOH pretreated soy spent flakes following LPMO treatment in combination with EG and BG for 0-237 
72 hrs.  We observe that all three of the LPMOs evaluated (TrCel61A, Aspte6, and Talle1) show a 238 
significant hydrolytic boosting effect when compared to samples treated without LPMO. Statistical 239 
evaluation by the Tukey-Kramer HSD method was conducted and the results are presented in 240 
Figure 3. Additional statistical evaluation with two-way analysis of variance (ANOVA) describes the 241 
significant correlation between glucose release and both reaction time and LPMO treatment 242 
(Supplementary Information Section 5). This analysis confirms that the glucose release depends on 243 
the interaction of these factors, as evidenced by the data presented in Figure 3. In addition to the 244 
Tukey-Kramer analysis presented in Figure 3, additional Tukey pairwise comparisons were 245 
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conducted on the complete dataset in Figure 3 (irrespective of time point) and are provided in 246 
Supplementary Information Section 5. These results show that the LPMO treatments from 8-72 247 
hrs result in statistically significant increases in glucose release over the controls lacking LPMO. In 248 
addition, differences between the boosting effects of the three enzyme treatments are not 249 
statistically significant at each of these time points. The addition of TrCel61A, Aspte6, and Talle1 250 
result in glucose yield increases of 88%, 76%, and 55%, respectively, when compared to enzymatic 251 
treatment with EG and BG alone. TrCel61A and Aspte6 are capable of ~36% substrate glucose 252 
release after 72 hrs of reaction, the highest yields obtained in this study and a comparable result 253 
to those obtained in previous work with TrCel61A (34.48 ± 4.84%)26. It is also interesting to note 254 
the rate of reaction observed in Figure 3. Significant glucose release is obtained within the first 2 255 
hrs of reaction (10-15%), however no significant additional glucose release is observed from 2-4 256 
hrs. After 24 hrs of reaction, the samples treated with LPMOs capable of hydrolytic boosting begin 257 
to significantly differentiate themselves from controls. While samples containing Talle1 showed 258 
the highest glucose release after 24 hrs, the reaction appears to have been completed in this 259 
timeframe as no additional glucose release was observed beyond this point.  260 
In addition to evaluating the hydrolytic boosting activity of each LPMO alone, two-enzyme 261 
combinations of the top-performing LPMOs were also assessed. Figure 4 shows the glucose 262 
release from NaOH pretreated spent flakes after 72 hr incubation with these enzyme 263 
combinations. A one-way analysis of variance showed no statistically significant differences 264 
between these six treatments, indicating that the LPMO combinations tested are unable to 265 
increase the glucose release when compared with the individual LPMO treatments. Lastly, it 266 
should be noted that all hydrolytic boosting effects observed in Figures 3 and 4 were not present 267 
in the absence of ascorbic acid (results not shown). 268 
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The data presented in Figures 1 and 2 indicate that the three top-performing LPMOs from this 269 
study (TrCel61A, Aspte6, and Talle1) show similar oxidation on NaOH pretreated spent flakes. As 270 
described above, the hydrolytic boosting effect demonstrated in Figure 3 is consistent across these 271 
three enzymes as well, with Figure 4 showing that 50% of the LPMO dosage can be replaced with 272 
another similarly acting LPMO to result in comparable hydrolytic boosting effects. These results 273 
indicate that this is a more generalized effect, and not necessarily tied to the specific activity of an 274 
individual LPMO. However, the results presented above do show commonality between the 275 
LPMOs displaying activity on the pretreated spent flakes. TrCel61A, Aspte6, and Talle1 all show 276 
significant C4 oxidizing activity (Figures 1 and 2) as well as activity on Avicel®, suggesting a link 277 
between these features and activity on pretreated spent flakes.  278 
3. Conclusions 279 
In this study, we have characterized the LPMO activity of twenty-four enzymes against four 280 
substrates: PASC, native soy spent flakes, NaOH pretreated soy spent flakes, and Avicel® PH-101 281 
microcrystalline cellulose. Following expression in T. reesei, the enzymes were evaluated for the 282 
presence of N-terminal histidine and methylation of this histidine, with all enzymes showing these 283 
features. Twenty-one enzymes displayed oxidative activity on PASC, seven showed activity on 284 
Avicel®, seven showed activity on NaOH pretreated soy spent flakes, and none showed activity on 285 
native soy spent flakes. Of the seven LPMOs showing activity on pretreated soy spent flakes 286 
(TrCel61A, Chacr2, Aspfu1, Aspfu4, Aspfu5, Aspte6, and Talle1), three were selected as the top-287 
performing enzymes (TrCel61A, Aspte6, and Talle1). ESI MS-MS fragmentation analysis 288 
demonstrated predominantly C4 oxidizing activity in these enzymes, and the presence of C4 289 
oxidized compounds was confirmed with HPAEC analysis. These results show a link between an 290 
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LPMO’s C4 oxidizing ability, activity on the microcrystalline Avicel® substrate, and oxidative activity 291 
on pretreated soy spent flakes. This observed correlation between C4 oxidizing activity and activity 292 
on NaOH pretreated soy spent flakes demonstrates a link between substrate structure and LPMO 293 
oxidative regioselectivity. This observation may offer some insight into the reasons for the 294 
evolution of regioselectivity in LPMOs, and highlights the continued need for research in this area 295 
to more fully understand the reasons behind oxidative regioselectivity.  In addition to these 296 
observations, the hydrolytic boosting effect of these enzymes towards the enzymatic degradation 297 
of pretreated spent flakes by EG and BG was evaluated. Two of the enzymes (TrCel61A and Aspte6) 298 
showed the most significant hydrolytic boosting ability, with release of 36% substrate glucose 299 
after 72 hours compared with the 20% released in the absence of LPMO.  Investigations into the 300 
glucose release with LPMO combinations showed no direct evidence of increased hydrolytic 301 
boosting when compared to treatment with individual LPMOs. The current results further expand 302 
our understanding of the ability of LPMOs to degrade this complex substrate, and open new and 303 
exciting opportunities for the application of these enzymes in the enzymatic degradation of soy 304 
polysaccharides and other industrially-relevant substrates in the future. 305 
4. Materials and Methods 306 
4.1 Materials  307 
Soy spent flakes were obtained from DuPont™ Nutrition & Health – Protein Solutions (St. Louis, 308 
MO) as a by-product of the soy protein isolate production process. The material was lyophilized 309 
and ground to pass a USA-Standard ASTM 40-mesh screen. Avicel® PH-101 microcrystalline 310 
cellulose, L-fucose (Fuc), L-rhamnose (Rha), D-arabinose (Ara), D-galactose (Gal), D-glucose (Glc), D-311 
xylose (Xyl), D-glucuronic acid (GlcA), D-galacturonic acid (GalA), D-(+)-cellobiose, D-(+)-cellotriose, 312 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
16 
 
cellotetraose, cellopentaose, and cellohexaose were obtained from Sigma-Aldrich (St. Louis, MO). 313 
GE Healthcare PD MidiTrap G-25 columns were purchased from VWR (Radnor, PA). PASC was 314 
obtained from DuPont™ Industrial Biosciences (Palo Alto, CA) where it was prepared as described 315 
by Wood35. Invitrogen NuPAGE 4-12% Bis-Tris Gels, SeeBlue® Plus2 Pre-Stained Standard, and 316 
SimplyBlue™ SafeStain were obtained from Thermo Scientific (Waltham, MA). 317 
4.2 Chemicals  318 
Concentrated sodium hydroxide (50%; NaOH), 96% glacial acetic acid, copper(II) sulfate 319 
pentahydrate, methanol, acetonitrile, urea, ammonium bicarbonate, DL-dithiothreitol (DTT), 320 
iodoacetamide, formic acid, and trifluoroacetic acid (TFA) were all purchased from Sigma-Aldrich 321 
(St. Louis, MO).  L(+)-ascorbic acid AnalaR NORMAPUR® was obtained from VWR (Radnor, PA). 322 
Sodium azide (NaN3) was purchased from Merck Performance Materials (Darmstadt, Germany). 323 
The Bio-Rad Protein Assay Kit II (dye reagent and bovine serum albumin (BSA) standard) was 324 
obtained from Bio-Rad (Hercules, CA).  325 
4.3 Enzymes 326 
Twenty-four LPMOs (Table 1) were obtained from DuPont™ (Shanghai, China) following expression 327 
in a Trichoderma reesei (Hypocrea jecorina) strain deleted for the major cellulase genes and beta-328 
glucosidase as described in PCT Pat. Appl. Publ. No. WO2009/04848827. Expression was conducted 329 
with the native leader peptide for each protein. The amino acid sequences, including the leader 330 
peptide sequences, are provided in FASTA format in Supplementary Information Section 1. Cell 331 
debris was removed by centrifugation and the supernatant was concentrated using a VivaFlow50 332 
PES ultrafiltration membrane (MWCO 10 kDa) from Sartorius (Göttingen, Germany), with final 333 
protein concentrations (Table 1) determined as described in 4.5.3.  The purity of the enzymes 334 
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were assessed using SDS-PAGE gels (Supplementary Information Figure S1) as described in 4.5.4, 335 
and N-terminal characterization was performed as described in 4.5.5 to verify the expected 336 
presence of an N-terminal histidine with methylation of the imidazole11.  Endo-1,4-β-D-glucanase 337 
from Bacillus amyloliquefaciens (EC 3.2.1.4; GH5) with 3500U activity (17.07 mg/mL protein) and 338 
beta-glucosidase from Agrobacterium sp. (EC 3.2.1.21; GH1) with 600U activity (2.48 mg/mL 339 
protein) were obtained from Megazyme International (County Wicklow, Ireland). Trypsin from 340 
bovine pancreas (EC 3.4.21.4), α-Chymotrypsin from bovine pancreas (EC 3.4.21.1), and 341 
endoproteinase Asp-N from Pseudomonas fragi (EC 3.4.24.33) were obtained from Sigma-Aldrich 342 
(St. Louis, MO). 343 
4.4 Soy Spent Flake NaOH Pretreatment  344 
NaOH pretreated soy spent flakes were produced as described by Mittal, Katahira, Himmel & 345 
Johnson32. In brief, dry soy spent flakes were combined with 16.5% w/w NaOH in an amount of 346 
8.57 mg per mL of 16.5% w/w NaOH. This mixture was stirred under nitrogen at 25 °C for 2 hrs. 347 
Upon completion, the material was separated by centrifugation and the soluble fraction was 348 
decanted off with the remaining insoluble fraction re-diluted in MilliQ water to the original 349 
reaction volume and vortexed. The centrifugation, separation and dilution described above were 350 
repeated until the pH of the soluble fraction was neutral. The final, rinsed insoluble material was 351 
lyophilized and ground to pass a USA-Standard ASTM 40-mesh screen. 352 
4.5 Material Characterization 353 
4.5.1 High Performance Anion Exchange Chromatography with Pulsed Amperometric Detection 354 
(HPAEC-PAD) 355 
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The free monosaccharides in each sample were quantified by HPAEC-PAD using a Dionex ICS-3000 356 
Ion Chromatography system with a CarboPac® PA100 guard column (50 x 2 mm) followed by a 357 
CarboPac® PA100 analytical column (250 x 2 mm) and a PAD, all from Dionex Corporation 358 
(Sunnyvale, CA). The flow rate used was 0.25 mL/min under the following elution profile, with 359 
MilliQ water as eluent A and 600 mM NaOH as eluent B:  0-18 min, 1.5% B; 18-19 min, 1.5-75% B; 360 
19-29 min, 75% B; 29-29.1 min, 75-1.5% B; 29.1-43 min, 1.5% B.  Monosaccharides were 361 
quantified using both external calibration standards containing a mixture of Fuc, Rha, Ara, Gal, Glc, 362 
Xyl, GlcA, and GalA, as well as variable internal calibration with Fuc added to each sample in the 363 
range of 6-13 ppm. The standard curves for each sugar were fit with a linear calibration curve 364 
without offset, except for Fuc where a second order polynomial calibration curve without offset 365 
was used.  366 
HPAEC-PAD was also used for the analysis of the oxidation products of LPMO reactions using the 367 
method of Westereng et al.34. This involved the use of a Dionex ICS-3000 Ion Chromatography 368 
system with a CarboPac® PA1 analytical column (250 x 2 mm) and a PAD, all from Dionex 369 
Corporation (Sunnyvale, CA). Note that no guard column was used in these experiments. The flow 370 
rate used was 0.25 mL/min under the following elution profile, with 0.1 M NaOH as eluent A and 1 371 
M NaOAc in 0.1M NaOH as eluent B:  0-10min, 0-10% B; 10-35 min, 10-30% B; 35-40 min, 30-100% 372 
B (Dionex curve 6 - exponential); 40-41 min, 100-0% B; 41-50 min, 0% B. 373 
4.5.2 Direct Infusion Electrospray Ionization Mass Spectrometry (ESI-MS) 374 
Mass spectrometry analysis by ESI-MS was performed on a linear ion trap LTQ Orbitrap Fusion 375 
from Thermo Scientific (Waltham, MA) coupled to a TriVersa NanoMate® chip-based electrospray 376 
device from Advion (Ithaca, NY). The analyses were done by direct infusion to the MS without 377 
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chromatographic separation. Samples were prepared in a 96-well microtiter plate with a 378 
methanol:sample ratio of 1:2. The electrospray was controlled with Advion ChipSoft Manager 379 
version 8.3.1 and operated in positive mode with a gas pressure (N2) of 0.6 psi, voltage of 1.8 kV, 5 380 
µL tip collection, and sample temperature of 7 °C utilizing plastic tips (part no. 1004763) and a 5 381 
µm ESI Chip® (part no. 1003446).  Fluoranthene was used as an internal calibrant and the ion 382 
transfer tube temperature was set to 200 °C. The acquisition time was set to 2.0 min, with 383 
approximately 40 scans per minute for MS and MS-MS. MS full scans were performed in the m/z 384 
300–1,200 mass range, utilizing an Orbitrap detector at 120K resolution and 2 microscans. MS-MS 385 
scans were performed on Na-adducts with CID (collision-induced dissociation), using He as the 386 
colliding gas in the m/z 105–400 scan range with quadrupole isolation, Orbitrap detection at 15K 387 
resolution, an isolation window of 2, 50% collision energy, and 3 microscans. MS Data from ESI-MS 388 
was processed in Xcalibur 3.0.63 from Thermo Scientific (Waltham, MA). 389 
4.5.3 Measurement of total protein concentration 390 
Total protein concentration was measured using the Bio-Rad Colorimetric Protein Assay based on 391 
the Bradford method36. In brief, 50 µL of enzyme sample was combined with 2.5 mL of 4x diluted 392 
Protein Assay Dye Reagent Concentrate and incubated at room temperature for 5 mins. 393 
Absorbance was measured at 595 nm and compared to the absorbance measured against known 394 
concentrations of BSA from 0.1-0.9 mg/mL. All measurements were performed in duplicate.  395 
4.5.4 SDS-PAGE  396 
SDS-PAGE gels were run using an Invitrogen XCell SureLock™ Mini-Cell Electrophoresis system, 397 
Invitrogen NuPAGE 4-12% Bis-Tris Gels, and SeeBlue® Plus2 Pre-Stained Standard from Thermo 398 
Scientific (Waltham, MA). Proteins were incubated at 90 °C for 5 mins with 1.0 M sodium-399 
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phosphate buffer, pH 6 and sample buffer containing DTT and 1% bromophenol blue. Following 400 
electrophoresis, gels were stained with SimplyBlue™ SafeStain from Thermo Scientific (Waltham, 401 
MA). 402 
4.5.5 N-terminal Characterization with Liquid Chromatography-Mass Spectrometry (LC-MS) 403 
Proteomic analysis was performed using a modified spin filter protease digestion as previously 404 
described by Manza et al. and Wiśniewski et al.37, 38. Samples were reduced with DTT and alkylated 405 
with iodoacetamide prior to protease digestion. Amino acid sequences were used to select an 406 
optimal protease for N-terminal characterization: Chymotrypsin (Chacr1, Aspfu1, Aspfu2, Aspte2, 407 
Aspte5, Talle1, and TrCel61A), Trypsin (Aspfu3, Aspfu4, Aspfu5, Aspte6, Penci2, Aspte7, Aspte8, 408 
Malci2, Mycth1, and Mycth3), and Asp-N (Chacr2, Aspte1, Aspte3, Aspte4, Penci1, Malci1, and 409 
Mycth2). Following protease digestion, samples were dried in a Thermo Scientific (Waltham, MA) 410 
Savant™ SpeedVac™ at 45°C for 8 hrs, and dissolved in 100 µL of 0.1% TFA for LC-MS analysis.  411 
LC separation was performed using an UltiMate 3000 Nano LC system from Dionex Corporation 412 
(Sunnyvale, CA), a 5 µm Acclaim PepMap C18 guard column (20 mm x 100 µm) from Thermo 413 
Scientific (Waltham, MA), and a 3 µm ReproSil-Pur C18-AQ column (100 mm x 75 µm) from Dr. 414 
Maisch GmbH (Ammerbuch-Entringen, Germany). The flow rate used was 300 nL/min under the 415 
following elution profile, with H2O/formic acid (100:0.1) as eluent A and acetonitrile/formic acid 416 
(100:0.1) as eluent B:  0-3 min, 2% B; 3-21 min, 2-41% B; 21-23 min, 41-95% B; 23-29 min, 95% B; 417 
29-31 min, 95-2% B; 31-44 min, 2% B.  MS and MS-MS analysis by ESI-MS was performed in 418 
positive mode on a linear ion trap LTQ Orbitrap Fusion with a capillary temperature of 200°C, 2.1 419 
kV ESI voltage, and quadrupole isolation. For MS-MS analysis, both CID (collision-induced 420 
dissociation) and HCD (higher-energy collisional dissociation) fragmentation were performed. MS 421 
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data was processed in Xcalibur 3.0.63 from Thermo Scientific (Waltham, MA) and Mascot Server 422 
from Matrix Science Inc. (Boston, MA). A summary of the results from this analysis is provided in 423 
Supplementary Information Section 3. 424 
4.6 Enzymatic Reactions 425 
4.6.1 Primary LPMO Screening 426 
Reaction mixtures of 200 µL total volume contained 4 mg/mL substrate cellulose, 0.02% sodium 427 
azide, and 1 mM ascorbic acid in 10 mM Na-acetate, pH 6.0. All LPMOs were Cu(II) saturated by 428 
incubating 0.3 mg/mL protein in 10 mM Na-acetate, pH 6.0 with a 3-fold molar excess of Cu(II)SO4 429 
for 30 minutes at room temperature. Excess copper was removed by PD MidiTrap G-25 filtration, 430 
as described by Loose, Forsberg, Fraaije, Eijsink, & Vaaje-Kolstad39 with 10 mM Na-acetate, pH 6.0 431 
used in place of the 20 mM Tris-HCl, pH 8.0. LPMOs were dosed based on protein content at 0.2 432 
mg/mL. Samples were incubated at 40 °C with 600 rpm mixing for 24 hrs. Following the reaction, 433 
all enzyme samples were heat-inactivated through incubation at 95 °C for 5 min and centrifuged at 434 
16,300 x g for 20 mins to isolate the supernatants from the pellets. 435 
4.6.2 Glucose release with LPMO, endoglucanase, and beta-glucosidase  436 
All LPMOs were Cu(II) saturated as described in 4.6.1, however a protein concentration of 0.2 437 
mg/mL was used during copper saturation. LPMOs were dosed based on protein content at 0.05 438 
mg/mL with samples incubated at 40 °C with 600 rpm mixing for varying times from 0-72 hrs. For 439 
reactions utilizing a combination of LPMOs, the total LPMO protein dosage was divided equally, 440 
with the total maintained at 0.05 mg/mL. All reactions also contained endo-1,4-β-D-glucanase (EG) 441 
and beta-glucosidase (BG) dosed at 0.05 and 0.125 mg/mL, respectively. Following the reaction, all 442 
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enzyme samples were heat-inactivated through incubation at 95 °C for 5 min and centrifuged at 443 
16,300 x g for 20 mins to isolate the supernatants from the pellets. Glucose release was quantified 444 
by HPAEC-PAD as described in 4.5.1 and sample data was converted into substrate glucose 445 
released (%) by dividing the amount of glucose released in the enzyme treatment by the total 446 
amount present in the original reaction substrate and multiplying by 100. Glucose release was 447 
compared in Minitab® 17 from Minitab Inc. (State College, PA) using two-way analysis of variance 448 
and means comparisons by the Tukey pairwise comparison method. 449 
4.6.3 Beta-glucosidase treatment of LPMO reaction products 450 
Following LPMO enzymatic treatment, supernatants were treated with beta-glucosidase from 451 
Agrobacterium sp. to degrade non-C4 oxidized reaction products for analysis with HPAEC-PAD as 452 
described in 4.5.1. Beta-glucosidase was dosed based on protein at 0.05 mg/mL in 100 µL 453 
reactions containing 40% sample from the primary enzymatic treatment in 10 mM Na-acetate 454 
buffer, pH 6.0. Samples were incubated at 40 °C with 600 rpm shaking for 20 hrs. Following the 455 
reaction, beta-glucosidase was heat-inactivated by incubating the samples at 95 °C for 5 min and 456 
samples were analyzed by HPAEC-PAD using the method of Westereng et al.34. 457 
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Figure Captions 474 
Figure 1 – ESI CID MS-MS fragmentation of the DP2 oxidized product (m/z 381.10) from LPMO 475 
treated PASC after 24 hrs. Masses are labeled based on expected fragmentation from the C4 476 
oxidized product Glc4gemGlc (blue) and/or the C1 oxidized product GlcGlc1A (red). A: TrCel61A; B: 477 
Aspte6; C: Talle1; D: Expected fragmentation products from Glc4gemGlc and GlcGlc1A. 478 
Parenthesis indicate an unlikely product. 479 
Figure 2 – HPAEC-PAD profile of LPMO treated NaOH pretreated soy spent flakes both with (black, 480 
1 nC offset) and without (red) ascorbic acid as per Westereng et al.34. A: TrCel61A; B: Aspte6; C: 481 
Talle1; D: DP 2-6 cello-oligosaccharides. 482 
Figure 3 – Glucose release from NaOH pretreated soy spent flakes following treatment with LPMO 483 
(0.05 mg/mL protein), EG (0.05 mg/mL protein), and BG (0.125 mg/mL protein) in the presence of 484 
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1 mM ascorbic acid, as determined by HPAEC-PAD analysis. Data are shown as averages of 485 
duplicate analyses with standard deviations given by error bars. Tukey-Kramer HSD comparisons 486 
are provided for each time point with data points marked by differing letters at a given timepoint 487 
signifying statistically different means.  488 
Figure 4 – Glucose release from NaOH pretreated soy spent flakes following 72 hr treatment with 489 
LPMO(s) (0.05 mg/mL protein), EG (0.05 mg/mL protein), and BG (0.125 mg/mL protein) in the 490 
presence of 1 mM ascorbic acid, as determined by HPAEC-PAD analysis. Samples contain either a 491 
single LPMO (red) or two LPMOs (blue). Data are shown as averages of duplicate analyses with 492 
standard deviations given by error bars. One-way analysis of variance showed no statistically 493 
significant differences (p > 0.05) between the six treatments presented.  494 
Table Captions 495 
Table 1 – LPMOs utilized in this study listed with their reference ID, native organism, NCBI 496 
reference ID29, presence of an InterPro predicted C-terminal cellulose binding domain (CBD)30, and 497 
measured protein concentration. 498 
Table 2 – LPMO activity on PASC, native soy spent flakes, NaOH pretreated soy spent flakes, and 499 
Avicel®. Legend: - = no activity observed; + = weak activity; ++ = moderate activity; +++ = strong 500 
activity. 501 
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Table 1: 
LPMO ID Native Organism NCBI Reference ID 
InterPro 
Predicted CBD 
[Protein] 
(mg/mL) 
TrCel61A Trichoderma Reesei UniProt:O14405 Yes 38.30 
Chacr1 Chaetosartorya cremea - Yes 0.37 
Chacr2 Chaetosartorya cremea - - 0.46 
Aspfu1 Aspergillus fumigatus - Yes 0.38 
Aspfu2 Aspergillus fumigatus - Yes 0.40 
Aspfu3 Aspergillus fumigatus GenBank: GAQ10694.1 - 0.65 
Aspfu4 Aspergillus fumigatus - Yes 0.48 
Aspfu5 Aspergillus fumigatus GenBank: GAQ07946.1 - 0.55 
Aspte1 Aspergillus terreus - - 0.65 
Aspte2 Aspergillus terreus - Yes 0.74 
Aspte3 Aspergillus terreus - - 0.56 
Aspte4 Aspergillus terreus - - 0.66 
Aspte5 Aspergillus terreus - Yes 0.67 
Aspte6 Aspergillus terreus - Yes 0.59 
Penci1 Penicillium citrinum - - 0.46 
Penci2 Penicillium citrinum - - 0.25 
Aspte7 Aspergillus terreus GenBank: GAQ40595.1 Yes 0.35 
Aspte8 Aspergillus terreus - - 0.23 
Malci1 Malbranchea cinamomea - - 0.21 
Malci2 Malbranchea cinamomea - - 0.36 
Mycth1 Myceliophthora thermophila - - 0.16 
Mycth2 Myceliophthora thermophila - Yes 0.28 
Mycth3 Myceliophthora thermophila - - 0.31 
Talle1 Talaromyces leycettanus - Yes 0.56 
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Table 2: 
LPMO PASC Native Soy NaOH Soy Avicel® 
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Figure 4: 
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Highlights 
• Twenty-four LPMOs were investigated for activity on NaOH pretreated soy spent flake. 
• Seven LPMOs showed activity on pretreated soy spent flake.  
• Oxidative activity (C1, C4, and C1-C4) was determined with ESI-MS and HPAEC-PAD. 
• Two LPMOs (TrCel61A and Aspte6) showed significant hydrolytic boosting. 
• LPMOs boost glucose release from soy spent flakes by EG and BG by more than 75%. 
